MXPA02001204A - Compuestos calciliticos. - Google Patents
Compuestos calciliticos.Info
- Publication number
- MXPA02001204A MXPA02001204A MXPA02001204A MXPA02001204A MXPA02001204A MX PA02001204 A MXPA02001204 A MX PA02001204A MX PA02001204 A MXPA02001204 A MX PA02001204A MX PA02001204 A MXPA02001204 A MX PA02001204A MX PA02001204 A MXPA02001204 A MX PA02001204A
- Authority
- MX
- Mexico
- Prior art keywords
- calcilytic compounds
- calcilytic
- compounds
- disorders
- novel methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se proveen nuevos metodos para tratar enfermedades o trastornos de huesos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14677899P | 1999-07-31 | 1999-07-31 | |
PCT/US2000/020834 WO2001008673A1 (en) | 1999-07-31 | 2000-07-31 | Calcilytic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02001204A true MXPA02001204A (es) | 2004-05-21 |
Family
ID=22518969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02001204A MXPA02001204A (es) | 1999-07-31 | 2000-07-31 | Compuestos calciliticos. |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1200076A4 (es) |
JP (1) | JP2003505502A (es) |
KR (1) | KR20020016928A (es) |
CN (1) | CN1367687A (es) |
AU (1) | AU764716B2 (es) |
BR (1) | BR0012921A (es) |
CA (1) | CA2380081A1 (es) |
CO (1) | CO5180628A1 (es) |
CZ (1) | CZ2002360A3 (es) |
EC (1) | ECSP003590A (es) |
HK (1) | HK1046238A1 (es) |
HU (1) | HUP0202167A3 (es) |
IL (1) | IL147875A0 (es) |
MX (1) | MXPA02001204A (es) |
NO (1) | NO20020466L (es) |
PE (1) | PE20010459A1 (es) |
PL (1) | PL353318A1 (es) |
TR (1) | TR200200278T2 (es) |
UY (1) | UY26265A1 (es) |
WO (1) | WO2001008673A1 (es) |
ZA (1) | ZA200200784B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY159417A (en) * | 2000-01-24 | 2017-01-13 | Smithkline Beecham Corp | Calcilytic compounds |
US20030018203A1 (en) | 2002-07-17 | 2003-01-23 | Largo Maria Amparo | Calcilytic compounds |
US6756480B2 (en) | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
MY143244A (en) | 2002-11-26 | 2011-04-15 | Smithkline Beecham Corp | Calcilytic compounds |
US7205322B2 (en) | 2003-02-12 | 2007-04-17 | Bristol-Myers Squibb Company | Thiazolidine compounds as calcium sensing receptor modulators |
US7265145B2 (en) | 2003-05-28 | 2007-09-04 | Bristol-Myers Squibb Company | Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method |
TW200845956A (en) * | 2006-12-18 | 2008-12-01 | Smithkline Beecham Corp | Calcilytic compounds |
EP2797591A1 (en) * | 2011-12-27 | 2014-11-05 | Ubaldo Armato | Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies |
GB201217330D0 (en) | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
CN108420814A (zh) * | 2017-02-15 | 2018-08-21 | 四川大学 | 一种nps-2143用于抗菌的新用途 |
CN116173187B (zh) * | 2023-03-14 | 2024-05-10 | 哈尔滨医科大学 | 降钙素在制备防治支架内再狭窄药物中的应用、药物涂层支架及制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL191027B1 (pl) * | 1996-04-09 | 2006-03-31 | Nps Pharma Inc | Pochodna α,α-dipodstawionej aryloalkiloaminy, kompozycja farmaceutyczna i zastosowanie α,α-dipodstawionej aryloalkiloaminy |
AR014975A1 (es) * | 1998-04-08 | 2001-04-11 | Nps Pharma Inc | Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento |
PE20000415A1 (es) * | 1998-04-08 | 2000-05-21 | Smithkline Beecham Corp | Compuestos calciliticos |
-
2000
- 2000-07-28 CO CO00056902A patent/CO5180628A1/es not_active Application Discontinuation
- 2000-07-28 EC EC2000003590A patent/ECSP003590A/es unknown
- 2000-07-31 BR BR0012921-6A patent/BR0012921A/pt not_active Application Discontinuation
- 2000-07-31 PL PL00353318A patent/PL353318A1/xx unknown
- 2000-07-31 TR TR2002/00278T patent/TR200200278T2/xx unknown
- 2000-07-31 CZ CZ2002360A patent/CZ2002360A3/cs unknown
- 2000-07-31 HU HU0202167A patent/HUP0202167A3/hu unknown
- 2000-07-31 PE PE2000000756A patent/PE20010459A1/es not_active Application Discontinuation
- 2000-07-31 WO PCT/US2000/020834 patent/WO2001008673A1/en active Application Filing
- 2000-07-31 CA CA002380081A patent/CA2380081A1/en not_active Abandoned
- 2000-07-31 EP EP00952319A patent/EP1200076A4/en not_active Withdrawn
- 2000-07-31 IL IL14787500A patent/IL147875A0/xx unknown
- 2000-07-31 JP JP2001513403A patent/JP2003505502A/ja not_active Withdrawn
- 2000-07-31 AU AU65041/00A patent/AU764716B2/en not_active Ceased
- 2000-07-31 MX MXPA02001204A patent/MXPA02001204A/es active IP Right Grant
- 2000-07-31 UY UY26265A patent/UY26265A1/es not_active Application Discontinuation
- 2000-07-31 KR KR1020027001298A patent/KR20020016928A/ko not_active Application Discontinuation
- 2000-07-31 CN CN00811177A patent/CN1367687A/zh active Pending
-
2002
- 2002-01-29 NO NO20020466A patent/NO20020466L/no not_active Application Discontinuation
- 2002-01-29 ZA ZA200201784A patent/ZA200200784B/xx unknown
- 2002-10-15 HK HK02107473.9A patent/HK1046238A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
BR0012921A (pt) | 2002-06-18 |
HK1046238A1 (zh) | 2003-01-03 |
HUP0202167A2 (en) | 2002-10-28 |
ECSP003590A (es) | 2002-02-25 |
JP2003505502A (ja) | 2003-02-12 |
ZA200200784B (en) | 2003-01-29 |
AU764716B2 (en) | 2003-08-28 |
PL353318A1 (en) | 2003-11-17 |
KR20020016928A (ko) | 2002-03-06 |
UY26265A1 (es) | 2001-03-16 |
EP1200076A4 (en) | 2005-02-09 |
AU6504100A (en) | 2001-02-19 |
EP1200076A1 (en) | 2002-05-02 |
IL147875A0 (en) | 2002-08-14 |
NO20020466L (no) | 2002-03-20 |
CO5180628A1 (es) | 2002-07-30 |
NO20020466D0 (no) | 2002-01-29 |
PE20010459A1 (es) | 2001-06-11 |
HUP0202167A3 (en) | 2006-07-28 |
TR200200278T2 (tr) | 2002-06-21 |
CN1367687A (zh) | 2002-09-04 |
CZ2002360A3 (cs) | 2002-10-16 |
WO2001008673A1 (en) | 2001-02-08 |
CA2380081A1 (en) | 2001-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
ZA200109073B (en) | Compositions for treatment of disorders of the oesophagus. | |
DE60023043T2 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
PL344304A1 (en) | Combination therapy for treatment of bipolar disorders | |
GB0108592D0 (en) | Therapeutic agents | |
AU6530600A (en) | Use of neurotoxin for treating cardiac muscle disorders | |
AU3998400A (en) | Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor | |
MY124786A (en) | Bis-arylsulfones | |
IL142900A0 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
UA66865C2 (uk) | Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти) | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
UA72948C2 (uk) | Заміщені похідні фенілпіперазину, фармацевтична композиція та спосіб лікування афективних або неврологічних захворювань і розладів | |
TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
MXPA02001204A (es) | Compuestos calciliticos. | |
IL150060A0 (en) | Novel purines | |
ZA200003768B (en) | Methods and compositions for treating diseases and conditions of the eye. | |
NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
GB9907571D0 (en) | Compounds | |
MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
AU2002227895A1 (en) | Sulphonamides for the treatment of central nervous system diseases | |
MXPA01007952A (es) | Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas. | |
IL162053A0 (en) | Method for the treatment of bone disorders | |
TWI245756B (en) | Improved process for the preparation of 1,3-substituted indenes | |
AU2002235202A1 (en) | Treatment of bone disorders by modulation of fgfr3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |